跳至主要内容
临床试验/CTRI/2018/03/012314
CTRI/2018/03/012314已完成不适用

Evaluation of Dermatological Safety of Investigational Products by Primary Irritation Patch Test on Healthy Human Volunteers of varied skin types.

ITC LIMITED ITC Life Sciences and Technology Centre1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2017年10月10日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
1
主要终点
patch test on healthy human volunteers of varied

研究概览

简要总结

Single Application, occlusive, Closed Patch Test is conducted to measure the irritation potential of cosmetic products on the skin.

Objective: To evaluate the dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types.

Duration of study: 8 days study

**Kinetics: T0 (**Evaluation of test sites by Dermat and Subject,

Patch application)**,**T+30mins post patch application, T1(Patch removal, Evaluation of test sites by Dermat and Subject post 30 minutes of patch removal), T2(Evaluation of test sitesby Dermat and Subject post 24 hrs of  patch removal), T8 (Evaluation of test sitesby Dermat and Subject post 1 week of patch removal and tracking the positive cases)

Population 24 healthy subjects(12 males + 12 females) The subjects are selected on the

basis of skin types:

3 males + 3 females for dry skin

3 males + 3 females for oily skin

3 males + 3 females for combination skin

3 males + 3 females for normal skin

**Products:**Soap (TSP 108-165), Soap (TSP 118-01B), Soap (TSP 118-02B), Soap (TSP 118-03B), Soap (TSP 118-04B), Soap (TSP 118-05B), Soap (TSP 118-06B), Soap (TSP 118-07B), Soap (TSP 115-170A), Soap (TSP 115-170B).

Positive control: 3% SLS

The test area is checked for erythema and oedema caused due to the products and

compared with positive control

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) Subjects representing varied skin types (ideally equal representation of all 4 skin types – Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period.

排除标准

  • For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis.

结局指标

主要结局

patch test on healthy human volunteers of varied

时间窗: T0 | T30 minutes post patch application | T1 | T2 | T8

To evaluate the dermatological safety of

时间窗: T0 | T30 minutes post patch application | T1 | T2 | T8

investigational products by primary irritation

时间窗: T0 | T30 minutes post patch application | T1 | T2 | T8

skin types

时间窗: T0 | T30 minutes post patch application | T1 | T2 | T8

次要结局

  • not applicable(not applicable)

研究者

发起方
ITC LIMITED ITC Life Sciences and Technology Centre
申办方类型
Other [multinational]

研究点 (1)

Loading locations...

相似试验